JPS5920217A - 尿素を安定に含む水性ゼリ−状組成物 - Google Patents
尿素を安定に含む水性ゼリ−状組成物Info
- Publication number
- JPS5920217A JPS5920217A JP13074982A JP13074982A JPS5920217A JP S5920217 A JPS5920217 A JP S5920217A JP 13074982 A JP13074982 A JP 13074982A JP 13074982 A JP13074982 A JP 13074982A JP S5920217 A JPS5920217 A JP S5920217A
- Authority
- JP
- Japan
- Prior art keywords
- urea
- composition
- ammonium
- aqueous
- carboxyvinyl polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title claims abstract description 54
- 239000004202 carbamide Substances 0.000 title claims abstract description 54
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 17
- 150000003868 ammonium compounds Chemical class 0.000 claims abstract description 15
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000002585 base Substances 0.000 claims abstract description 10
- 235000019270 ammonium chloride Nutrition 0.000 claims abstract description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims abstract description 3
- 235000011130 ammonium sulphate Nutrition 0.000 claims abstract description 3
- 235000015110 jellies Nutrition 0.000 claims description 20
- 239000008274 jelly Substances 0.000 claims description 20
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 12
- 229910021529 ammonia Inorganic materials 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 3
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 claims description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 2
- 239000005695 Ammonium acetate Substances 0.000 claims description 2
- 239000004251 Ammonium lactate Substances 0.000 claims description 2
- 239000004254 Ammonium phosphate Substances 0.000 claims description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 2
- 235000019257 ammonium acetate Nutrition 0.000 claims description 2
- 229940043376 ammonium acetate Drugs 0.000 claims description 2
- 229940059265 ammonium lactate Drugs 0.000 claims description 2
- 235000019286 ammonium lactate Nutrition 0.000 claims description 2
- VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 claims description 2
- 229910000148 ammonium phosphate Inorganic materials 0.000 claims description 2
- 229940010556 ammonium phosphate Drugs 0.000 claims description 2
- 235000019289 ammonium phosphates Nutrition 0.000 claims description 2
- RZOBLYBZQXQGFY-HSHFZTNMSA-N azanium;(2r)-2-hydroxypropanoate Chemical compound [NH4+].C[C@@H](O)C([O-])=O RZOBLYBZQXQGFY-HSHFZTNMSA-N 0.000 claims description 2
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 16
- 238000000354 decomposition reaction Methods 0.000 abstract description 12
- 229940079593 drug Drugs 0.000 abstract description 9
- 239000002537 cosmetic Substances 0.000 abstract description 8
- 102000011782 Keratins Human genes 0.000 abstract description 6
- 108010076876 Keratins Proteins 0.000 abstract description 6
- 239000003112 inhibitor Substances 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 239000003513 alkali Substances 0.000 abstract description 2
- 150000007514 bases Chemical class 0.000 abstract description 2
- 239000003906 humectant Substances 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 9
- 229940124597 therapeutic agent Drugs 0.000 description 7
- 206010020649 Hyperkeratosis Diseases 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 208000001126 Keratosis Diseases 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 206010017533 Fungal infection Diseases 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- -1 carboxyvinyl Chemical group 0.000 description 2
- 239000000490 cosmetic additive Substances 0.000 description 2
- 208000024386 fungal infectious disease Diseases 0.000 description 2
- 206010021198 ichthyosis Diseases 0.000 description 2
- 201000002597 ichthyosis vulgaris Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- 206010001557 Albinism Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- FUSNMLFNXJSCDI-UHFFFAOYSA-N tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 description 1
- 229960004880 tolnaftate Drugs 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13074982A JPS5920217A (ja) | 1982-07-27 | 1982-07-27 | 尿素を安定に含む水性ゼリ−状組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13074982A JPS5920217A (ja) | 1982-07-27 | 1982-07-27 | 尿素を安定に含む水性ゼリ−状組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5920217A true JPS5920217A (ja) | 1984-02-01 |
| JPS6241645B2 JPS6241645B2 (enrdf_load_stackoverflow) | 1987-09-03 |
Family
ID=15041714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13074982A Granted JPS5920217A (ja) | 1982-07-27 | 1982-07-27 | 尿素を安定に含む水性ゼリ−状組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5920217A (enrdf_load_stackoverflow) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6130567A (ja) * | 1984-07-23 | 1986-02-12 | Shiseido Co Ltd | 尿素の安定化法 |
| JPS63166825A (ja) * | 1986-12-27 | 1988-07-11 | Hisamitsu Pharmaceut Co Inc | 尿素を安定に含む透明ゲル製剤 |
| JPS63174924A (ja) * | 1987-01-14 | 1988-07-19 | Toko Yakuhin Kogyo Kk | 軟膏基剤および軟膏剤 |
| JPH01294625A (ja) * | 1988-05-19 | 1989-11-28 | Hisamitsu Pharmaceut Co Inc | 消炎鎮痛外用剤 |
| WO2001049283A1 (de) * | 2000-01-03 | 2001-07-12 | Karl Kraemer | Zubereitungen zur atraumatischen nagelentfernung |
| JP2005060386A (ja) * | 2003-07-29 | 2005-03-10 | Rohto Pharmaceut Co Ltd | 皮膚外用剤 |
| JP2006524199A (ja) * | 2003-04-24 | 2006-10-26 | ロレアル | 美容的ピーリング方法 |
| EP1476131A4 (en) * | 2002-02-15 | 2007-03-07 | Hydron Technologies Inc | COMPOSITIONS AND METHODS FOR ADMINISTERING COSMETICS FOR THE SKIN |
| JP2007230943A (ja) * | 2006-03-02 | 2007-09-13 | Nitto Boseki Co Ltd | ハンド用保湿液および容器入りハンド用保湿液製品 |
| JP2009102358A (ja) * | 2003-07-29 | 2009-05-14 | Rohto Pharmaceut Co Ltd | 皮膚外用剤 |
| JP2011074033A (ja) * | 2009-09-30 | 2011-04-14 | Kobayashi Pharmaceutical Co Ltd | 外用医薬組成物 |
-
1982
- 1982-07-27 JP JP13074982A patent/JPS5920217A/ja active Granted
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6130567A (ja) * | 1984-07-23 | 1986-02-12 | Shiseido Co Ltd | 尿素の安定化法 |
| JPS63166825A (ja) * | 1986-12-27 | 1988-07-11 | Hisamitsu Pharmaceut Co Inc | 尿素を安定に含む透明ゲル製剤 |
| JPS63174924A (ja) * | 1987-01-14 | 1988-07-19 | Toko Yakuhin Kogyo Kk | 軟膏基剤および軟膏剤 |
| JPH01294625A (ja) * | 1988-05-19 | 1989-11-28 | Hisamitsu Pharmaceut Co Inc | 消炎鎮痛外用剤 |
| WO2001049283A1 (de) * | 2000-01-03 | 2001-07-12 | Karl Kraemer | Zubereitungen zur atraumatischen nagelentfernung |
| EP1476131A4 (en) * | 2002-02-15 | 2007-03-07 | Hydron Technologies Inc | COMPOSITIONS AND METHODS FOR ADMINISTERING COSMETICS FOR THE SKIN |
| JP2006524199A (ja) * | 2003-04-24 | 2006-10-26 | ロレアル | 美容的ピーリング方法 |
| JP2005060386A (ja) * | 2003-07-29 | 2005-03-10 | Rohto Pharmaceut Co Ltd | 皮膚外用剤 |
| JP2009102358A (ja) * | 2003-07-29 | 2009-05-14 | Rohto Pharmaceut Co Ltd | 皮膚外用剤 |
| JP2007230943A (ja) * | 2006-03-02 | 2007-09-13 | Nitto Boseki Co Ltd | ハンド用保湿液および容器入りハンド用保湿液製品 |
| JP2011074033A (ja) * | 2009-09-30 | 2011-04-14 | Kobayashi Pharmaceutical Co Ltd | 外用医薬組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6241645B2 (enrdf_load_stackoverflow) | 1987-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5561264B2 (ja) | 育毛組成物 | |
| JPH07316023A (ja) | 育毛料 | |
| JPS5920217A (ja) | 尿素を安定に含む水性ゼリ−状組成物 | |
| JP2020037517A (ja) | ミノキシジルを含有する外用組成物、および、ミノキシジルの析出防止方法 | |
| JP2002326913A (ja) | 育毛組成物 | |
| JP7346838B2 (ja) | 外用医薬組成物 | |
| US20030045503A1 (en) | Composition for the relief of joint pain and myofascial pain and method of preparing same | |
| US6977081B1 (en) | Facial cream composition containing allantoin | |
| JP5881879B1 (ja) | 尋常性ざ瘡改善用外用組成物 | |
| JP4926354B2 (ja) | 皮膚外用剤 | |
| CN117098525A (zh) | 用于护理角蛋白材料的组合物 | |
| JP2011046690A (ja) | 育毛剤組成物 | |
| JP3434635B2 (ja) | 含水化粧料の変臭・変色防止方法 | |
| JPH03157311A (ja) | にきび用化粧料 | |
| JPH01316308A (ja) | 白髪防止剤 | |
| JPH0233013B2 (ja) | Sokonchiryozai | |
| JP3582951B2 (ja) | 皮膚外用剤 | |
| JPH08283138A (ja) | 皮膚化粧料 | |
| JP2016193881A (ja) | 尋常性ざ瘡改善用外用組成物 | |
| JP3836051B2 (ja) | アルブチンを含有する皮膚外用剤 | |
| JPH1179937A (ja) | ニキビ改善用皮膚外用剤 | |
| JPS6393708A (ja) | 〔ベンゾ−１，２，４−チアジアジン〕−１−ジオキシド誘導体溶解組成物 | |
| JPS61200918A (ja) | 外用消炎鎮痛剤 | |
| JP2869168B2 (ja) | 育毛剤及びそれを含有する養毛化粧料 | |
| JPS63208513A (ja) | 〔ベンゾ−１，２，４−チアジアジン〕−１−ジオキシド誘導体溶解組成物 |